Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Medication Overuse Headache

ClinicalTrials.gov ID: NCT03971071

Public ClinicalTrials.gov record NCT03971071. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 5:20 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of Erenumab in Adults With Chronic Migraine and Medication Overuse Headache

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Study 20170703 is a phase 4, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of erenumab against placebo in participants with chronic migraine (CM) who have a history of at least 1 preventive treatment failure and are diagnosed with medication overuse headache (MOH).

Study identification

NCT ID
NCT03971071
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Amgen
Industry
Enrollment
620 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 7, 2019 (Actual)
Primary completion
Dec 1, 2022 (Actual)
Completion
Jun 13, 2023 (Actual)
Last update posted
Sep 19, 2025

2019 – 2023

United States locations

U.S. sites
32
U.S. states
22
U.S. cities
31
Facility City State ZIP Site status
Core Healthcare Group Cerritos California 90703 —
Axiom Research Colton California 92324 —
Clinical Research Institute Los Angeles California 90048 —
The George Washington Medical Faculty Associates Washington D.C. District of Columbia 20037 —
University of Miami Miller School of Medicine Miami Florida 33136 —
Floridian Clinical Research LLC Miami Lakes Florida 33016 —
Clinical Neuroscience Solutions Orlando Florida 32801 —
Emerald Coast Center for Neurological Disorders Pensacola Florida 32504 —
University of South Florida Tampa Florida 33612 —
Saint Lukes Clinic Meridian Idaho 83642 —
Fort Wayne Neurological Center Fort Wayne Indiana 46804 —
College Park Family Care Center Overland Park Kansas 66212 —
Collective Medical Research Prairie Village Kansas 66208 —
University of Kentucky Lexington Kentucky 40536 —
DelRicht Research New Orleans Louisiana 70124 —
Neurology Center of New England PC Foxborough Massachusetts 02035 —
Michigan Head Pain and Neurological Institute Ann Arbor Michigan 48104 —
Clinical Research Institute Inc Minneapolis Minnesota 55402 —
Citizens Memorial Healthcare Bolivar Missouri 65613 —
Mercy Research St Louis Missouri 63141 —
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756 —
Dent Neurosciences Research Center Amherst New York 14226 —
Onsite Clinical Solutions LLC Charlotte North Carolina 28277 —
Clinical Trial Investigator Clinical Research Center Cincinnati Ohio 45212 —
Cleveland Clinic Cleveland Ohio 44195 —
Allegheny Health Network Cancer Institute at Mellon Pavilion Pittsburgh Pennsylvania 15224 —
Preferred Primary Care Physicians, Inc Pittsburgh Pennsylvania 15236 —
Nashville Neuroscience Group Nashville Tennessee 37203 —
Texas Neurology, PA Dallas Texas 75214 —
Wasatch Clinical Research LLC Salt Lake City Utah 84107 —
Marshall University Huntington West Virginia 25701 —
Aurora BayCare Medical Center Green Bay Wisconsin 54311 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 62 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03971071, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 19, 2025 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03971071 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →